MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
2.120
-0.110 (-4.93%)
Nov 21, 2024, 3:49 PM EST - Market open

MAIA Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
8.697.1510.9510.570.661.71
Cash & Short-Term Investments
8.697.1510.9510.570.661.71
Cash Growth
42.36%-34.70%3.56%1493.82%-61.19%-
Other Receivables
0.050.140.30.04--
Receivables
0.050.140.30.04--
Prepaid Expenses
0.50.270.550.050.080.02
Total Current Assets
9.247.5611.8110.670.751.73
Long-Term Deferred Charges
--0.210.65--
Other Long-Term Assets
0000--
Total Assets
9.247.5712.0211.330.751.73
Accounts Payable
1.151.641.170.960.150.17
Accrued Expenses
2.463.32.11.191.510.18
Short-Term Debt
----0.020.03
Current Portion of Long-Term Debt
----0.01-
Other Current Liabilities
-----0
Total Current Liabilities
3.614.943.272.151.690.37
Long-Term Debt
----0.430.01
Other Long-Term Liabilities
4.022.150.25-0.240.03
Total Liabilities
7.627.093.512.152.360.41
Common Stock
000000
Additional Paid-In Capital
85.2964.4752.7337.6212.69.23
Retained Earnings
-83.66-63.98-44.21-28.44-15.93-9.3
Comprehensive Income & Other
-0.01-0.02-0.02--0-0.1
Total Common Equity
1.620.488.519.18-3.34-0.17
Minority Interest
----1.721.5
Shareholders' Equity
1.620.488.519.18-1.621.32
Total Liabilities & Equity
9.247.5712.0211.330.751.73
Total Debt
----0.460.03
Net Cash (Debt)
8.697.1510.9510.570.21.68
Net Cash Growth
42.36%-34.70%3.56%5195.01%-88.08%-
Net Cash Per Share
0.440.541.182.000.050.44
Filing Date Shares Outstanding
25.3320117.944.433.77
Total Common Shares Outstanding
23.9716.9910.967.584.433.77
Working Capital
5.632.638.548.53-0.951.36
Book Value Per Share
0.070.030.781.21-0.75-0.05
Tangible Book Value
1.620.488.519.18-3.34-0.17
Tangible Book Value Per Share
0.070.030.781.21-0.75-0.05
Source: S&P Capital IQ. Standard template. Financial Sources.